The action of special peptides that induce the growth of ovarian cancer tumors can be blocked, thus inhibiting the growth of those tumors and limiting their size, researchers have found. Receptors for this peptide can be found on ovarian cancer tumors, and by blocking the ability of the peptide to react with these receptors, the influence of GRP on tumor growth is limited.
Oncogenes cause cell mutations and tumor growth under a prescribed set of circumstances.
This research shows that certain oncogenes can be downregulated by using specific GRP antagonists. These findings could potentially influence the development of new treatment methods for ovarian cancers. Researchers believe that GRP influences the expression of oncogenes, which play a role in cell mutation and proliferation in some kinds of cancers This article was prepared by Cancer Weekly editors from staff and other reports. This information is provided for educational purposes only. Please read the disclaimer .